KabaFusion is a home infusion company that truly excels in its approach to patient care and positive clinical outcomes. Our success is the result of teamwork from our dedicated staff, who are empowered to make a difference.
Putting the "CARE" back in healthcare
KabaFusion is a pharmacist-owned, patient-focused home infusion company specializing in intravenous immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG) and acute home-infusion iv therapies. We have state-of-the-art compounding pharmacies across the country, with service capabilities in over 40 states.
At KabaFusion, we are guided by our commitment to positive clinical outcomes and excellence in specialty acute and immunoglobulin infusion. We are dedicated to working proactively with patients, healthcare providers and payors to provide comprehensive support before, during and after treatment.
KabaFusion was founded by Dr. Sohail Masood in 2010 and currently operates 27 fully accredited home infusion specialty pharmacies strategically located across the country.
KabaFusion pharmacies offer specialty infusion pharmacy services as well as home nursing support for a wide range of infusion therapies prescribed by physicians specializing in neurology, immunology, oncology, pain management, infectious disease, cardiology, dermatology and nutrition.
One of our main focuses is IVIG, a highly effective autoimmune drug. A high degree of expertise is required to procure the drug, obtain authorization, clinically manage the patient and properly bill and collect for this specialty infusion product in the home or in the physician’s clinic. IVIG is usually prescribed by neurologists, immunologists, dermatologists and infectious disease experts.
Our pharmacies are accredited by the Accreditation Commission for HealthCare (ACHC), and have received their Utilization Review Accreditation Commission (URAC) accreditation.
Our corporate headquarters are located in Cerritos, California and Lexington, Massachusetts.
The success of KabaFusion is the result of teamwork from our dedicated staff who truly believe in patient-focused infusion therapy.
KabaFusion features a diverse management team consisting of industry leaders with significant clinical, fiscal and payor experience and expertise. Senior management has established a corporate culture that embraces fiscal responsibility in the delivery of quality healthcare.
We are committed to providing the best possible outcomes for each and every one of our patients.
With over 30 years of experience and state-of-the-art facilities, we are the industry leader in home infusion.
Partnership
KabaFusion is a member of Novo Holdings A/S, a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation. Headquartered in Copenhagen with offices in Boston, San Francisco, and Singapore, Novo Holdings manages the assets of the Novo Nordisk Foundation with a focus on creating sustainable, long-term value. In addition to being the controlling shareholder in Novo Nordisk A/S and Novozymes A/S, Novo Holdings invests broadly in healthcare and life sciences companies at all stages of development. As a firm, Novo Holdings ultimately seeks to deliver returns that the Novo Nordisk Foundation can distribute for scientific, social, and humanitarian purposes. For more information, please visit www.novoholdings.dk.
Accreditations
Locations
Pharmacy Locations
& growing
Infusion Nursing Locations
& growingÂ
Timeline
State-of-the-Art Pharmacies
Leadership
Meet our leadership team and learn about their passion and what drives them to do the work that they do.Â
The Latest Industry News, Learning & More
From company updates and tips on home care, to patient stories, here’s what’s happening in the world of Infusion Therapy.
KabaFusion Acquires Infusion Care Assets from Coram® to Expand its Nationwide Footprint of Patient-Focused Services
LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) — KabaFusion, a nationally recognized leader in home and alternative site infusion, today announced it has closed on a transaction with Coram pursuant to which it has acquired 6 locations that will serve as pharmacies and ambulatory infusion suites, which transaction is consistent with Coram’s previously announced downsizing.